Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer

NCT03827044 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class

Stopped POLEM encountered significant recruitment challenges. With little prospect of recruiting to target the decision to close was made.

Conditions

Interventions

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators